Next Article in Journal
Therapeutic Drug Monitoring of Ivacaftor, Lumacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis: Where Are We Now?
Previous Article in Journal
Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence
Previous Article in Special Issue
Stimuli Responsive Nitric Oxide-Based Nanomedicine for Synergistic Therapy
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(8), 1673; https://doi.org/10.3390/pharmaceutics14081673
Action Date Notes Link
article pdf uploaded. 11 August 2022 15:46 CEST Version of Record https://www.mdpi.com/1999-4923/14/8/1673/pdf-vor
article xml file uploaded 12 August 2022 07:39 CEST Original file -
article xml uploaded. 12 August 2022 07:39 CEST Update https://www.mdpi.com/1999-4923/14/8/1673/xml
article pdf uploaded. 12 August 2022 07:39 CEST Updated version of record https://www.mdpi.com/1999-4923/14/8/1673/pdf
article html file updated 12 August 2022 07:41 CEST Original file -
article html file updated 12 August 2022 10:13 CEST Update https://www.mdpi.com/1999-4923/14/8/1673/html
Back to TopTop